San Diego Business Journal

SD HEALTHCARE

Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...

Cidara Completes $32M Financing

Biopharmaceutical company Cidara Therapeutics Inc. completed a $32 million Series A financing round, the company said.

Seragon Being Purchased in Deal Potentially Worth $1.7 Billion

Seragon Pharmaceuticals, a privately held San Diego-based drug developer targeting breast cancer treatment, agreed to be acquired by Genentech, a subsidiary of the Roche Group, for $725 million in cash plus future payments which could reach $1 billion if specific milestones are reached, the companies announced.

Tease photo

Scripps Opens Critical Care Pavilion as Part of $94M Expansion in Encinitas

Scripps Health announced the opening of the Leichtag Foundation Critical Care Pavilion, which includes a new emergency department and inpatient rooms at Scripps Memorial Hospital Encinitas.

Trovagene Secures Debt Facility of $15 Million

Trovagene Inc., a San Diego molecular diagnostics company, said it secured an unrestricted debt facility of $15 million from Silicon Valley bank and Oxford Finance LLC.

Cidara Therapeutics Completes $32M Series A Financing Round

Cidara Therapeutics, a privately held bio-pharmaceutical company formerly known as K2 Therapeutics, said it completed a $32 million Series A financing round.

Ambrx Withdraws IPO

La Jolla-based biotech Ambrx Inc. withdrew its plans for an initial public offering, citing current market conditions, according to Renaissance Capital.

Tease photo

Palomar Health Names Hemker as New CEO, President

Palomar Health has named Robert Hemker as its new president and chief executive officer.

S.D. Life Science Cluster Healthy

San Diego ranks third among U.S. cities for the economic health of its life sciences cluster, scoring high in a newly issued report on factors including research facilities, funding access and critical mass of startup and midtier companies.

Tease photo

Palomar Health Names Hemker New President, CEO

Palomar Health has named Robert Hemker as its new president and chief executive officer.

San Diego Ranks Third Nationally Among Life Science Clusters

San Diego ranks third among U.S. cities for the economic health of its life sciences cluster, scoring high in a newly issued report on factors including research facilities, funding access and critical mass of startup and midtier companies.

Tease photo

Halozyme Earns $5 Million Milestone Payment

San Diego-based Halozyme Therapeutics Inc. said the commercial launch of a cancer therapeutic in Europe has triggered a $5 million milestone payment to company under an agreement with Roche.

Tease photo

Ligand Inks Licensing Agreement With TG Therapeutics

Ligand Pharmaceuticals Inc. has signed an exclusive global license agreement with TG Therapeutics Inc. for the development and commercialization of Ligand’s Interleukin-1 Receptor Associated Kinase-4 — or IRAK-4 — inhibitors, Ligand announced.

Sorrento Therapeutics Registers for Possible IPO for Animal Health Subsidiary

Sorrento Therapeutics Inc. has submitted a draft registration statement on a confidential basis with the U.S. Securities and Exchange Commission for a possible initial public offering of shares of common stock of its wholly-owned subsidiary, Ark Animal Health Inc.

Hillary Clinton Set for Keynote Conversation at BIO Convention

Former Secretary of State Hillary Clinton is scheduled to participate in a keynote conversation at the BIO International Convention at the San Diego Convention Center June 25, according to BIO.

Free Testing Cups Cost Company

A federal jury in Florida on June 16 decided that San Diego-based Millennium Laboratories violated laws against kickbacks by giving physicians free urine testing cups, and it awarded a Baltimore-based competitor nearly $15 million in mostly punitive damages.